A recent meta-analysis [52] suggested that ER negativity was an independent risk factor for BMs development, and that the triple-negative (ER, PgR and HER-2 negative) breast cancers showed shorter time to BMs development from the diagnosis of the primary tumor, compared to other breast cancer subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.